IP Library Assignment 020055/0441
Patent Assignment
Reel/Frame 020055/0441

Assignment of Assignor's Interest

Recorded: 2007-11-01 Pages: 26
Assignors
BLAND-WARD, PHILIP ANTONY
Executed: 2006-01-12
BUCHANAN, ANDREW GRIER
Executed: 2006-01-10
FRANKS, RUTH
Executed: 2006-01-12
HART, CELIA PATRICIA
Executed: 2007-01-16
MATTHEWS, CARL ANTHONY
Executed: 2006-01-12
SLEEMAN, MATTHEW ALEXANDER
Executed: 2006-01-12
THOM, ALBERT GEORGE
Executed: 2006-01-11
WELSH, FRASER EWING
Executed: 2006-01-12
Assignee
CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
MILSTEIN BUILDING, GRANTA PARK, CAMBRIDGE, CB1 6GH, UNITED KINGDOM
Covered Property (1)
Specific Binding Members For Ngf
Patent: 9,315,571 →
Application: 11/814,668 →
Publication: US 2008/0107658
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 1, 2007
From: HAWKINSON, JON ERIC
To: ELAN PHARMACEUTICALS, INC.
Reel/Frame 020055/0489 →
Assignment of Assignor's Interest Nov 1, 2007
From: ELAN PHARMACEUTICALS, INC.
To: ELAN PHARMA INTERNATIONAL LIMITED
Reel/Frame 020055/0520 →
Certificate of Incorporation on Change of Name Feb 20, 2008
From: CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
To: MEDIMMUNE LIMITED
Reel/Frame 020533/0540 →
Certificate of Incorporation on Conversion to a Designated Activity Company Feb 23, 2018
From: PERRIGO PHARMA INTERNATIONAL LIMITED
To: PERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY COMPANY
Reel/Frame 045418/0272 →
Change of Name Feb 23, 2018
From: ELAN PHARMA INTERNATIONAL LIMITED
To: PERRIGO PHARMA INTERNATIONAL LIMITED
Reel/Frame 045430/0541 →